Whether your insurance covers weight loss medication depends on the type of plan you have, who your employer is, and sometimes what other health conditions you carry. Right now, only about 19% of large employers cover GLP-1 medications like Wegovy or Zepbound for weight loss. That number is growing fast, but it still means most people face either a coverage denial or significant out-of-pocket costs. Here’s how to figure out where you stand.
Employer-Sponsored Insurance: A Mixed Picture
If you get insurance through your job, coverage depends heavily on the size of your company and the benefit package your employer chose. Among firms with 200 or more workers, 19% cover GLP-1 medications for weight loss as of 2025. But that average hides a wide range. Only 16% of mid-size companies (200 to 999 employees) cover these drugs, compared to 30% of companies with 1,000 to 4,999 workers. The best odds are at the largest employers: 43% of firms with 5,000 or more employees now cover weight loss medications, up from 28% just one year earlier.
Even when your employer does offer coverage, expect conditions. About a third of companies that cover GLP-1s for weight loss now require you to meet with a dietitian, case manager, or therapist, or to participate in a lifestyle program before the medication is approved. That requirement tripled from the previous year, when only 10% of firms had it. Some employers also set BMI thresholds higher than what the FDA requires, limiting coverage to people with a BMI of 35 or 40 rather than the FDA-approved threshold of 30.
The quickest way to find out is to call the number on the back of your insurance card and ask specifically whether your plan covers the medication your doctor is prescribing, and for what diagnosis. The answer can differ depending on whether the prescription is for weight loss versus diabetes or heart disease prevention.
What the FDA Actually Approved These Drugs For
GLP-1 medications have been approved for three groups of adults: people with type 2 diabetes, people with a BMI of 30 or higher (obesity), and people with a BMI between 27 and 30 who also have at least one weight-related health condition. Those qualifying conditions include cardiovascular disease, high blood pressure, high cholesterol, prior stroke, prior heart attack, and chest pain.
This matters because your insurance company will check your diagnosis against what the FDA has approved. If your BMI is between 27 and 30, you’ll need documentation of a related health condition. If your BMI is 30 or above, you meet the clinical threshold on weight alone, though your insurer may still impose a higher cutoff.
Medicare: Mostly Excluded, With One Exception
Medicare Part D has a longstanding exclusion for drugs used for weight loss. Federal law specifically bars Part D from covering “agents when used for anorexia, weight loss, or weight gain.” So if you’re on Medicare and want a GLP-1 purely to lose weight, Part D will not pay for it.
There is one important exception. In March 2024, the FDA expanded Wegovy’s approval to include reducing the risk of heart attacks, strokes, and cardiovascular death in people who have both cardiovascular disease and obesity or overweight. Because that approval is for heart disease prevention rather than weight loss alone, Medicare Part D plans can now cover Wegovy for that specific use. You’d need to have both a higher BMI and established heart disease to qualify, and your plan will likely require prior authorization to confirm the prescription is for heart risk reduction, not weight management.
A proposed rule from late 2024 would reinterpret the weight loss exclusion so it no longer applies to drugs used to treat obesity as a medical condition. If finalized, this could open Medicare Part D coverage to millions of enrollees. But as of now, the exclusion remains in effect for weight loss use.
Medicaid Coverage Varies by State
Medicaid programs are required to cover Wegovy for enrollees who have both higher weight and cardiovascular disease risk, following the same logic as the Medicare exception. Beyond that, state Medicaid programs set their own rules about whether to cover weight loss medications. Coverage varies widely, and you’ll need to check with your specific state’s Medicaid program or your managed care plan to find out what’s available to you.
What Prior Authorization Looks Like
Even when your plan does cover weight loss medication, you’ll almost certainly face prior authorization. This is the process where your doctor submits paperwork proving you meet the insurer’s criteria before the pharmacy can fill the prescription. Understanding what insurers look for can help you prepare.
A typical prior authorization form asks your doctor to document your baseline weight and BMI, confirm you meet the age requirements (at least 12 for Wegovy, at least 18 for Zepbound), and verify that your BMI is 30 or above, or between 27 and 30 with a qualifying condition. The list of qualifying conditions on insurance forms tends to be broader than the minimum FDA label. One major insurer’s form includes high blood pressure, type 2 diabetes, kidney disease, polycystic ovarian syndrome, abnormal cholesterol, non-alcoholic fatty liver disease, and osteoarthritis in weight-bearing joints, among others.
Many plans also require that you’ve tried and failed cheaper weight loss medications first. One insurer’s form asks for documented evidence that you did not lose at least 5% of your body weight after three months on each of several older, less expensive weight loss drugs. This “step therapy” requirement can add months to the process, so ask your doctor early what your plan requires and start documenting results from any prior treatments.
You’ll also likely need to show you’re enrolled in or following a lifestyle program. This can be a formal program through your health system or something like Weight Watchers or Noom. The key is that it’s documented in your medical chart before the authorization is submitted.
How to Improve Your Chances of Approval
Start by having your doctor check your plan’s specific formulary and prior authorization criteria. These vary between insurers and even between plans within the same insurer. What one Blue Cross plan covers, another may not.
Make sure your medical records clearly document your BMI, any weight-related conditions, and your history of trying other approaches to weight management. If your insurer requires step therapy with older medications, your doctor should note in your chart exactly how long you took each one and what the results were. If you had side effects or a medical reason not to try a particular drug, that should be documented too, since most plans allow exceptions when there’s a documented intolerance or contraindication.
If your initial prior authorization is denied, you have the right to appeal. Ask your doctor’s office to help with the appeal and include any additional medical records that support why the medication is necessary for your health. Many denials are overturned on appeal when stronger documentation is provided.
What You’ll Pay Out of Pocket
Without insurance, GLP-1 medications can cost well over $1,000 a month. With insurance coverage, your actual cost depends on your plan’s copay or coinsurance structure and whether the drug is on a preferred or specialty tier.
Manufacturers offer savings cards that can reduce costs for people with commercial insurance. These programs typically lower your copay for a set period, though the specific terms change frequently. They generally do not apply to government insurance like Medicare or Medicaid. Check the manufacturer’s website for the medication you’re prescribed to see current offers and eligibility rules. Your doctor’s office or pharmacist can also help you find available discount programs.